Cargando…
The Pathology of T Cells in Systemic Lupus Erythematosus
Systemic lupus erythematosus (SLE) is characterized by the production of a wide array of autoantibodies. Thus, the condition was traditionally classified as a “B-cell disease”. Compelling evidence has however shown that without the assistance of the helper T lymphocytes, it is indeed difficult for t...
Autores principales: | Mak, Anselm, Kow, Nien Yee |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Hindawi Publishing Corporation
2014
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4017881/ https://www.ncbi.nlm.nih.gov/pubmed/24864268 http://dx.doi.org/10.1155/2014/419029 |
Ejemplares similares
-
Costimulatory Pathways: Physiology and Potential Therapeutic Manipulation in Systemic Lupus Erythematosus
por: Kow, Nien Yee, et al.
Publicado: (2013) -
Imbalance between Endothelial Damage and Repair: A Gateway to Cardiovascular Disease in Systemic Lupus Erythematosus
por: Mak, Anselm, et al.
Publicado: (2014) -
Endothelial dysfunction in systemic lupus erythematosus – a case-control study and an updated meta-analysis and meta-regression
por: Mak, Anselm, et al.
Publicado: (2017) -
T Cells, Interleukin-2 and Systemic Lupus Erythematosus—From Pathophysiology to Therapy
por: Mak, Anselm
Publicado: (2022) -
Environmental Factors, Toxicants and Systemic Lupus Erythematosus
por: Mak, Anselm, et al.
Publicado: (2014)